BES, EES, and ZES-R in Real World Practice

A trial with no phase registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 1960 participants.

Also called NCT01397175

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 1,960 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01397175
Other papers using this trial's data
  • Randomized Comparison of Everolimus- and Zotarolimus-Eluting Coronary Stents With Biolimus-Eluting Stents in All-Comer Patients Circulation. Cardiovascular interventions, 2020-03 DOI, PubMed 32160779

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
South Korea (from the registry)
Registry status
  • Terminated (from the registry)

Technical summary

Registry record NCT01397175. Randomized; single masking; primary purpose treatment. Start 2013-01-16 (actual); primary completion 2017-12-05 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
BES, EES, and ZES-R in Real World Practice
Acronym
CHOICE
Intervention (Device)
Biolimus-eluting stent
Intervention (Device)
Everolimus-eluting stent
Intervention (Device)
Zotarolimus-eluting stent
Lead sponsor
Yonsei University (class: other)
Collaborator
Gangwon Cardiovascular Health Research Institute (class: other)

Record details

Record id
cardio:ct-nct01397175
Content hash
bcdbe78659cca5271b1d7021e73ae2e27fa9fbe17cc3feca448478202a11613b